CK Group are recruiting for a Antibody Research Scientist, to join a global pharmaceutical company, based in Slough, on a contract basis initially for 12 months. Salary: PAYE £20.68 per hour or UMB £28.16 per hour. Antibody Research Scientist Role: Perform small-scale transient mammalian transfections and purify monoclonal antibodies using automated techniques. Troubleshoot purification and quality issues, interpret data, and propose creative solutions to ensure the delivery of high-quality reagents. Lead and support the development, optimisation, and implementation of automated/robotic high-throughput platforms for antibody expression and purification. Apply data analysis and visualisation tools to improve workflows and troubleshoot bottlenecks. Collaborate with cross-functional teams to ensure timely communication of progress, issues, and solutions. Your Background : Competence in using data management systems, including Excel, logistics databases, and sample tracking systems. Expertise in mammalian cell culture (CHO, HEK), including aseptic techniques and maintaining cell stocks. Proficiency with antibody/protein purification systems such as AKTA and Unicorn software. Familiarity with automation and robotics for high-throughput purification workflows. Interest in or experience with machine learning software for data analysis and optimisation of processes. Company: Our client is a global biopharmaceutical company, focused on creating value for people living with severe diseases in immunology and neurology now and into the future. Location: This role is based at our client’s site in Slough. Apply: It is essential that applicants hold entitlement to work in the UK. Please quote reference 117 313. Please note: This role may be subject to a satisfactory basic Disclosure and Barring Service (DBS) check. If this position isn't suitable but you are looking for a new role, or if you are interested in seeing what opportunities are out there, head over to our LinkedIn page (cka-group) and follow us to see our latest jobs and company news.